1 / 30

Chapter 38 Thyroid & antithyroid drugs

Chapter 38 Thyroid & antithyroid drugs. Thyroid gland. The thyroid gland consits of two lobes & is situated in the lower neck The thyroid gland secretes three main hormones: thyroxine (T 4 ), triiodothyronine (T 3 ) and calcitonin

Download Presentation

Chapter 38 Thyroid & antithyroid drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 38Thyroid & antithyroid drugs

  2. Thyroid gland • The thyroid gland consits of two lobes & is situated in the lower neck • The thyroid gland secretes three main hormones: thyroxine (T4), triiodothyronine (T3) and calcitonin • T4 and T3 are critically important for normal growth and development and for energy metabolism • Calcitonin is involved in the control of plasma Ca2+

  3. Synthesis, storage, release, and interconversion of thyroid hormones • More than 99% of the circulating thyroid hormones are protein bound, primarily thyroxin-binding globulin (TBG) • T4 is produced in the greatest amounts, but T3 is four times more potent in activity • T4 is converted into T3 in the tissues, especially in the liver, & this process may be an additional site for regulation

  4. Thyroid-Pituitary Relationships • Hypothalamic cells secrete thyrotropin-releasing hormone (TRH) • TRH is secreted into capillaries of the pituitary portal venous system, and in the pituitary gland • The binding of TRH to its receptor, a GPCR, stimulates the Gq-PLC-IP3-Ca2+ pathway and activates PKC, ultimately stimulating the synthesis and release of TSH by the thyrotropes • Somatostatin, dopamine, and pharmacological doses of glucocorticoids inhibit TRH-stimulated TSH secretion

  5. Thyroid-Pituitary Relationships • TSH in turn stimulates the Gs-adenylyl cyclase–cyclic AMP pathway in the thyroid cell to increase the synthesis and release of T4 and T3 • T3 and T4 act in a negative feedback fashion in the pituitary to block the action of TRH and in the hypothalamus to inhibit the synthesis and secretion of TRH • The thyroid gland also regulates its uptake of iodide and thyroid hormone synthesis by intrathyroidal mechanisms that are independent of TSH. These mechanisms are primarily related to the level of iodine in the blood

  6. + + + + - _ - _ _ _ Control of thyroid function Cold Acute psychosis Circardian & pulsatile rhythms Stress Hypothalamus TRH SST Dopamine Corticoids Anterior pitutary gland TSH I- (high) Thyroid gland I- (low) T3 & T4

  7. Effects of Thyroid Hormones • Growth & development • Thyroid hormone is critical for the development and functioning of nervous, skeletal, and reproductive tissues • Thyroid hormone plays a critical role in brain development during the period of active neurogenesis (up to 6 months postpartum) • The absence of thyroid hormone during the period of active neurogenesis leads to irreversible mental retardation (cretinism) and is accompanied by multiple morphological alterations in the brain

  8. Effects of Thyroid Hormones • Cardiovascular effects • Thyroid hormone influences cardiac function by direct and indirect actions: • Thyroid hormones directly increase the expression of the α gene and decreasing the expression of the β gene of the sarcomeric myosin heavy chains • Thyroid hormones indirectly alter the sensitivity of the cardiac myocyte to catecholamines responsiveness to catecholamines, possibly due to changes in expression of myocardial beta- adrenergic receptors

  9. Effects of Thyroid Hormones • Metabolic effects • The thyroid hormones produce a general increase in the metabolism of carbohydrates, fats and proteins, and regulate these processes in most tissues

  10. Effects of Thyroid Hormones • Calorigenic effect • Most peripheral tissues (heart, skeletal muscle, liver, and kidney) are stimulated markedly by thyroid hormone to thyroid hormone is increased O2 consumption & heat production • Several organs, including brain, gonads, and spleen, are unresponsive to the calorigenic effects of thyroid hormone

  11. Abnormalities of thyroid function

  12. Hypothyroidism • Hypothyroidism is manifested largely by a reversible slowing down of all body functions • Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) accounts for the majority of cases • Hypothyroidism is diagnosed by elevated TSH • The most severe expression of severe, long-standing hypothyroidism is myxedemacoma • In infants and children, there is striking retardation of growth and development that results in dwarfism and irreversible mental retardation

  13. Clinical Features of Hypothyroidism Puffy Eyes Tiredness Enlarged Thyroid (Goiter) Forgetfulness/Slower Thinking Moodiness/ Irritability Hoarseness/Deepening of Voice Depression Persistent Dry or Sore Throat Inability to Concentrate Thinning Hair/Hair Loss Difficulty Swallowing Loss of Body Hair Slower Heartbeat Dry, Patchy Skin Menstrual Irregularities/Heavy Period Weight Gain Infertility Cold Intolerance Constipation Elevated Cholesterol Muscle Weakness/Cramps Family History of Thyroid Disease or Diabetes

  14. Management of Hypothyroidism • There are no drugs that specifically augment the synthesis or release of thyroid hormones • The only effective treatment for hypothyroidism is to administer the thyroid hormones themselves as replacement therapy • Drug-induced hypothyroidism can be treated by simply removing the depressant agent

  15. Thyroid preparations • Major indications: • hormone replacement therapy in patients with hypothyroidism or cretinism • TSH suppression therapy in patients with thyroid cancer and occasionally those with nontoxic goiter • Thyroid hormones abosorption is impaired in severe myxedema with ileus(IV T4 or sometimes T3)

  16. Levothyroxine (T4) • It is the preparation of choice for maintenance of plasma T4 and T3 concentrations for thyroid hormone replacement therapy in hypothyroid patients • Its long half-life (7 days) allows for convenient once daily administration • Since much of the T4 is deiodinatedto T3; thus, administration of T4 produces both hormones

  17. Liothyronine (T3) • It is not used for maintenance thyroid hormone replacement therapy because of: • shorter half-life and duration of action • Cost • Difficulty in monitoring by conventional lab methods • hormone activity and consequent greater risk of cardiotoxicity • Most appropriate use: • short-term suppression of TSH in patients undergoing surgery for thyroid cancer • Initial therapy of myxedema and myxedema coma

  18. Liotrix • 4:1 mixture of levothyroxine sodium and liothyronine sodium • Based on the idea of combining T4 and T3 in replacement therapy so as to mimic the normal ratio secreted by the thyroid gland • It does not appear that liotrix offers any therapeutic advantage over levothyroxine alone

  19. Adverse effects • The toxicity of thyroxine is directly related to the hormone level (i.e., symptoms of hyperthyroidism) • In children: restlessness, insomnia, and accelerated bone maturation and growth • In adults, increased nervousness, heat intolerance, episodes of palpitation and tachycardia, or unexplained weight loss may be the presenting symptoms • Chronic overtreatment with T4 , particularly in elderly patients, can increase the risk of atrial fibrillation and accelerated osteoporosis

  20. Hyperthyroidism • Hyperthyroidism refers to excess synthesis and secretion of thyroid hormones by the thyroid gland • It is associated with a number of disease states, including Graves’ disease, toxic adenoma, and goiter • Thyrotoxicosis is the term applied to any condition caused by elevated levels of circulating free thyroid hormones

  21. Signs and Symptoms of Hyperthyroidism Hoarseness/Deepening of Voice Nervousness/Tremor Mental Disturbances/ Irritability Persistent Dry or Sore Throat Difficulty Swallowing Difficulty Sleeping Palpitations/Tachycardia Bulging Eyes/Unblinking Stare/ Vision Changes Impaired Fertility Enlarged Thyroid (Goiter) Weight Loss or Gain Menstrual Irregularities/Light Period Heat Intolerance Increased Sweating Frequent Bowel Movements Sudden Paralysis Warm, Moist Palms Family History ofThyroid Diseaseor Diabetes First-Trimester Miscarriage/ Excessive Vomiting in Pregnancy

  22. Hyperthyroidism • Goal of treatment: • Inhibit synthesis of the hormone • Block the release of the hormone from the follicle • Approach to hyperthyroidism treatment: • Inhibit synthesis of the hormone • Block the release of the hormone • Remove/destroy part of the thyroid with surgical or radiation interventions

  23. Inhibition of thyroid hormone synthesisThioamides • Agents: propythiouracil and methimazole • Thionamides are the primary drugs used to decrease thyroid hormone production • Used in the management of hyperthyroidism and thyrotoxic crisis and in the preparation of patients for surgical subtotal thyroidectomy

  24. Inhibition of thyroid hormone synthesisThioamides • They have a slow onset of pharmacological effect • Since the synthesis rather than the release of hormones is affected, the onset of these agents is slow (3-4 weeks) before stores of T4 are depleted

  25. Anion inhibitors • Monovalent anions: perchlorate (ClO4–), pertechnetate (TcO4–), and thiocyanate (SCN–) • MOA: block uptake of iodide by the gland through competitive inhibition of the iodide transport mechanism • Clinical uses: block thyroidal reuptake of I– in patients with iodide-induced hyperthyroidism (eg, amiodarone-induced hyperthyroidism) • Potassium perchlorate is rarely used clinically because it is associated with aplastic anemia

  26. Inhibition of hormone releaseIodides • The effects of iodide on the thyroid gland are complex: • Inhibit hormone release, possibly through inhibition of thyroglobulin proteolysis (major) • Inhibit organification • Decrease the size and vascularity of the hyperplastic gland • Improvement in symptoms occurs rapidly—within 2–7 days

  27. Iodides • Clinical Uses • Treatement of severe thyrotoxicosis or thyroid crisis when a rapid decrease in plasma T4 and T3 is desirable • Preoperative preparation of patients about to undergo total or subtotal surgical thyroidectomy

  28. Iodide • Iodide should not be used alone • Iodide should not be used alone, because the gland will escape from the iodide block in 2–8 weeks, and its withdrawal may produce severe exacerbation of thyrotoxicosis in an iodine-enriched gland • Iodide use should be initiated only after onset of thioamide treatment & not used if radioactive iodine therapy is planned • Chronic use of iodides in pregnancy should be avoided

  29. Radioactive Iodine (131I) • Used for treatment of thyrotoxicosis • 131I is taken up and trapped in the same manner as I-.The ablative effect is exerted primarily through β- particle emissions, which destroy thyroid tissue • Advantages: easy administration, effectiveness, low expense, and absence of pain • Major disadvantage is the development of hypothyroidism • Should not be administered to pregnant women or nursing mothers

  30. Adrenergic receptor blocking drugs • Rationale: reduction of sympathetic manifestations of thyrotoxicosis (thyroid storm) • Applicable drugs: • Beta adrenoceptor blockers without intrinsic sympathomimetic activity (propranolol) • Patients suffering from severe heart failure or asthma: CCB (diltiazem)

More Related